Literature DB >> 11108323

Stroke: epidemiology, clinical picture, and risk factors--Part I of III.

T J Tegos1, E Kalodiki, S S Daskalopoulou, A N Nicolaides.   

Abstract

The aim of this review is to present the current knowledge regarding stroke. It will appear in three parts (in part II the pathogenesis, investigations, and prognosis will be presented, while part III will consist of the management and rehabilitation). In the current part (I) the definitions of the clinical picture are presented. These include: amaurosis fugax, vertebrobasilar transient ischemic attack, and stroke (with good recovery, in evolution and complete). The role of the following risk factors is discussed in detail: age, gender, ethnicity, heredity, hypertension, cigarette smoking, hyperlipidemia, diabetes mellitus, obesity, fibrinogen and clotting factors, oral contraceptives, erythrocytosis and hematocrit level, prior cerebrovascular and other diseases, physical inactivity, diet and alcohol consumption, illicit drug use, and genetic predisposition. In particular, regarding the carotid arteries, the following characteristics are analyzed: atheroma, carotid plaque echomorphology, carotid stenosis, presence of ulcer, local variations in surface deformability, pathological characteristics, and dissection. Finally the significance of the cerebral collateral circulation and the conditions predisposing to cardioembolism and to cerebral hemorrhage are presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108323     DOI: 10.1177/000331970005101001

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

1.  MicroRNA-141 protects PC12 cells against hypoxia/reoxygenation-induced injury via regulating Keap1-Nrf2 signaling pathway.

Authors:  Bin Zhou; Hong-Yun Liu; Bao-Lian Zhu; Ai-Xia Yue
Journal:  J Bioenerg Biomembr       Date:  2019-07-04       Impact factor: 2.945

2.  Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.

Authors:  Linda C Johansson; Lars Frison; Ulrika Logren; Gunnar Fager; David Gustafsson; Ulf G Eriksson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  The effects of tibolone in older postmenopausal women.

Authors:  Steven R Cummings; Bruce Ettinger; Pierre D Delmas; Peter Kenemans; Victoria Stathopoulos; Pierre Verweij; Mirjam Mol-Arts; Lenus Kloosterboer; Lori Mosca; Claus Christiansen; John Bilezikian; Eduardo Mario Kerzberg; Susan Johnson; Jose Zanchetta; Diederich E Grobbee; Wilfried Seifert; Richard Eastell
Journal:  N Engl J Med       Date:  2008-08-14       Impact factor: 91.245

4.  Prediction of poor outcome in cerebellar infarction by diffusion MRI.

Authors:  Zahari Tchopev; Marc Hiller; Jiachen Zhuo; Joshua Betz; Rao Gullapalli; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

5.  Aptamer-functionalized nano-biosensors.

Authors:  Tai-Chia Chiu; Chih-Ching Huang
Journal:  Sensors (Basel)       Date:  2009-12-21       Impact factor: 3.576

6.  Potential application of hydrogen in traumatic and surgical brain injury, stroke and neonatal hypoxia-ischemia.

Authors:  Jan M Eckermann; Paul R Krafft; Lorelei Shoemaker; Robert E Lieberson; Steven D Chang; Austin Colohan
Journal:  Med Gas Res       Date:  2012-04-19

Review 7.  Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature.

Authors:  Vasileios Rafailidis; Ioannis Chryssogonidis; Thomas Tegos; Konstantinos Kouskouras; Afroditi Charitanti-Kouridou
Journal:  Insights Imaging       Date:  2017-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.